Roche Holding Ltd. (VTX:ROG) has been given a CHF 254 price target by stock analysts at Deutsche Bank AG in a report released on Friday. The firm presently has a “neutral” rating on the healthcare company’s stock. Deutsche Bank AG’s price target points to a potential upside of 10.39% from the company’s current price.
ROG has been the subject of several other reports. The Goldman Sachs Group, Inc. set a CHF 335 price objective on Roche Holding and gave the company a “buy” rating in a report on Thursday, August 24th. J P Morgan Chase & Co reissued a “buy” rating and issued a price objective on shares of Roche Holding in a report on Monday, October 16th. Baader Bank set a CHF 231 price objective on Roche Holding and gave the company a “neutral” rating in a report on Thursday, October 19th. Kepler Capital Markets set a CHF 230 price objective on Roche Holding and gave the company a “neutral” rating in a report on Monday, September 11th. Finally, Sanford C. Bernstein set a CHF 284 price objective on Roche Holding and gave the company a “buy” rating in a report on Thursday, July 27th. Two analysts have rated the stock with a sell rating, nine have assigned a hold rating and five have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of CHF 262.69.
Shares of Roche Holding (VTX:ROG) opened at CHF 230.10 on Friday. Roche Holding has a fifty-two week low of CHF 218.30 and a fifty-two week high of CHF 273.
ILLEGAL ACTIVITY NOTICE: “Roche Holding Ltd. (ROG) PT Set at CHF 254 by Deutsche Bank AG” was published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this piece of content on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright laws. The original version of this piece of content can be viewed at https://ledgergazette.com/2017/11/19/roche-holding-ltd-rog-pt-set-at-chf-254-by-deutsche-bank-ag.html.
Roche Holding Company Profile
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.